https://www.selleckchem.com/pr....oducts/azd0156-azd-0
Mycobacterium tuberculosis (Mtb) is a deadly tuberculosis (T-causing pathogen. The proteasome is vital to the survival of Mtb and is therefore validated as a potential target for anti-TB therapy. Mtb resistance to existing antibacterial agents has enhanced drastically, becoming a worldwide health issue. Therefore, new potential therapeutic agents need to be developed that can overcome the complications of TB. With this purpose, in the present study, 224,205 natural compounds from the ZINC database have been screened against t
Like
Comment
Share
